Lily Zhang
Ophthalmology · Miami, FLNPI 1043771850
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,986 of the $6,416 with a category attached, or 77.7%. 19 manufacturers reported payments, led by Glaukos Corporation at 31.7% of the total. 2025 is the largest year on record at $3,035, more than ten times the $25 reported in 2020.
Across 91 payments — averaging $70.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Glaukos Corporation$2K
- Alcon$2K
- Bausch & Lomb Americas Inc.$486
- Johnson & Johnson Surgical Vision, Inc.$344
- ANI Pharmaceuticals, Inc.$310
- Alimera Sciences, Inc.$293
- plus $1K from 13 others
Across 1 payment — averaging $2000.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Rxsight Inc$2K
What the payments were for
- Consulting fees$1,25019%
- Travel & lodging$1803%
- Food & beverage$4,98678%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Glaukos Corporation | 15 | $2,031 |
| Alcon | 27 | $1,841 |
| Bausch & Lomb Americas Inc. | 7 | $486 |
| Johnson & Johnson Surgical Vision, Inc. | 5 | $344 |
| ANI Pharmaceuticals, Inc. | 3 | $310 |
| Alimera Sciences, Inc. | 2 | $293 |
| Tarsus Pharmaceuticals, Inc. | 9 | $254 |
| Biotissue Holdings Inc. | 3 | $154 |
| Harrow Eye, LLC | 6 | $146 |
| Rxsight Inc | 2 | $142 |
| Dompe US, Inc. | 2 | $139 |
| Kedrion Biopharma, Inc. | 1 | $62 |
| Thea Pharma Inc. | 3 | $54 |
| Dutch Ophthalmic, USA | 1 | $32 |
| Mallinckrodt Hospital Products Inc. | 1 | $28 |
| Amgen | 1 | $27 |
| Oyster Point Pharma, Inc. | 1 | $26 |
| Genentech USA, Inc. | 1 | $25 |
| Sight Sciences, Inc. | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- iStent inject Trabecular Micro-Bypass System Model G2-M-IS$1,250
- Clareon$536
- Iluvien$293
- STELLARIS$286
- iStent$283
- iStent inject W$283
- PURIFIED CORTROPHIN GEL$278
- AMO PHACO NEEDLE$274
- AcrySof IQ VIVITY IOL$154
- KXL System$149
- Clareon PanOptix Pro$147
- IC-8 Apthera IOL$138
- IACCESS$134
- Photrexa Viscous and Photrexa$124
- AcrySof IQ PanOptix$124
- Rhopressa$122
- Rocklatan$122
- XDEMVY$118
- RXSIGHT CONTACT LENS$117
- RXSIGHT INJECTOR CARTRIDGE$117
How this compares
$6,416 in reported general payments places this provider in the 80th percentile of 1,405 ophthalmology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 27 | $19,242 |
| Prednisolone Acetate | 156 | $7,660 |
| MoxifloxacinMoxifloxacin Hcl | 85 | $2,611 |
| Fluorometholone | 31 | $2,404 |
| ValacyclovirValacyclovir Hcl | 31 | $1,921 |
| Ketorolac Tromethamine | 54 | $1,343 |
| Loteprednol Etabonate | 12 | $1,286 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 52 | $688 |
| Timolol Maleate | 15 | $409 |
| Brimonidine Tartrate | 25 | $393 |
| Polymyxin B Sul-TrimethoprimPolymyxin B Sulf/Trimethoprim | 45 | $349 |
| Latanoprost | 46 | $298 |
| ErythromycinErythromycin Base | 22 | $243 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 11 | $180 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Miami
- William TrattlerMiami$579K
- Jennifer LohMiami$545K
- Jayanth SridharMiami$525K
- Kendall DonaldsonMiami$349K
- Jaclyn KovachMiami$333K
- Andrew SchimelMiami$320K
- Carlos BuznegoMiami$287K
- Felipe MedeirosMiami$266K
- Michael YimMiami$161K
- Arnulfo MansurMiami$134K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.